Details for New Drug Application (NDA): 087854
✉ Email this page to a colleague
NDA 087854 describes THEOBID JR., which is a drug marketed by Whitby and is included in one NDA. Additional details are available on the THEOBID JR. profile page.
The generic ingredient in THEOBID JR. is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
The generic ingredient in THEOBID JR. is theophylline. There are thirty-six drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the theophylline profile page.
Summary for 087854
| Tradename: | THEOBID JR. |
| Applicant: | Whitby |
| Ingredient: | theophylline |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 087854
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, EXTENDED RELEASE;ORAL | Strength | 130MG | ||||
| Approval Date: | Mar 20, 1985 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
